Johanna Louhimo

Surgeon, mother, scientist, teacher. The truth IS out there.

[Terhi Ainiala @ainiala]

Mitä on pedagoginen johtaminen? Entä miten oppimista tulisi menestyksekkäästi johtaa? Kolme keskeistä: tavoitteet, vuorovaikutus, yhteisöllisyys.
@Ope_Aka #oppiminen #johtaminen @TiinaAiraksine1 @Anna_Parpala
https://t.co/Ldz1JmrTiD

[Sameer Raniga @samrad77]

This will be my pinned tweet. Till the end of time.

Let's demyth the contrast induced nephropathy (better contrast associated acute kidney injury).

Thank you @DGlaucomflecken

[Pim Teunissen @pim_teu]

The Dutch Obs&Gyn curriculum based on a focus on Growth and Outcomes (GO) is available in English, see https://t.co/Yn57Vtk09k

[Pim Teunissen @pim_teu]

Thank you and I completely agree. FYI the Dutch Obs&Gyn curriculum is available in English, see https://t.co/Yn57Vtk09k

[Johanna Louhimo @JLouhimo]

#ottawa2024 workshop kind of an interaction worked very well also in a huge plenary hall 😊 Thanks to you @pim_teu ! As we are struggling with implementing CBME in my institution, we should remember the growth mindset as well, not everything can be assessed with EPAs.

[Johanna Louhimo @JLouhimo]

Loved this episode of The PAPERs podcast, check it out if you are wondering about ChatGPT!
https://t.co/AcnLOpmTVY

[EBMA @EBMAorg]

We are happy to announce the confirmation of next EBMA Conference, with the theme “The Future of Assessment in Medical Education: Opportunities and Threats” to April 11-13, 2024, in Plymouth, UK.

Abstract submissions and the conference website will go live soon.

[EBMA @EBMAorg]

The call for abstracts and registration for the EBMA's 2024 conference are now open. Visit our website for full details. https://t.co/07LZDhbE7l

[Duodecim @DuodecimFi]

Veren tulo pyllystä on aina pelottavaa, mutta milloin lääkärin tulisi siitä huolestua ja milloin olisi hyvä tähystää? Uusimmassa Kimppakyyti-jaksossa näihin meille vastaa gastrokirurgi Johanna Louhimo.
Tervetuloa kyytiin!
https://t.co/Wpc3tlqKn1

[Kari Tikkinen @KariTikkinen]

Usein kuulee, että tarvitaan lisää lääkäreitä

Oikeasti tarvitaan lisää HYVIÄ lääkäreitä!

Miten? Kouluttamalla

Mitä voit tehdä sen eteen?

Jos lääketieteen kandi kysyy, että saako osallistua tai tutkia Sinua, jos vaan mitenkään mahdollista, niin vastaa myöntävästi, kiitos!

[Johanna Louhimo @JLouhimo]

Read: A view from the coffee room…what I regret most in my career https://t.co/2hZY7aW9vk

[Johanna Louhimo @JLouhimo]

@meducate @kookysang

[Johanna Louhimo @JLouhimo]

Why to do HPE research and how to get it through 🤗 @LaraVarpio #MedEdEdge

[Johanna Louhimo @JLouhimo]

One of the highligts of the #MedEdEdge

[Johanna Louhimo @JLouhimo]

What marks a truly succesful conference? Head of program committee moonwalking after the last session 🤩 #MedEdEdge @drjfrank

[Mushtaq Bilal, PhD @MushtaqBilalPhD]

Nature rejected her paper for not being original,

University of Pennsylvania (her employer) demoted her,

and yesterday Katalin Karikó won the Noble Prize in physiology.

In mid-2000s, Karikó and her Drew Weismann submitted their paper on mRNA (messenger Ribonucleic Acid) to Nature.

Nature desk rejected their paper for being "an incremental contribution" only. The paper was later published in another journal, Immunity.

Earlier in her career at the University of Pennsylvania, Karikó was demoted because her applications for grants kept getting rejected.
But Karikó persevered and kept on going.

In 2013, she joined BioNTech, a German company founded by two scientists, Uğur Şahin and Özlem Türeci. In 2018, BioNTech partnered with Pfizer to develop mRNA vaccines against the influenza virus.

When the COVID-19 hit the world, Karikó's research helped Pfizer to produce the first vaccine against the disease.

I don't know how the Nature editors who desk rejected Karikó's paper and the Penn administration who demoted her feel about Karikó Nobel Prize.

Takeaway: Many academics and scientists worry about getting published in "prestigious" journals. Instead of worrying about prestige, we should try to put our work out as quickly as possible like Karikó did.

Once you put your work out without caring about prestige, two good things happen:

1. Your work will lead to newer opportunities.
2. You will start getting feedback from the scholarly community, which you can use to iterate and improve.

Here's another interesting Nobel Prize story.

Peter Higgs, a British physicist, joined the University of Edinburgh in 1956. By 1964, Higgs has published his groundbreaking work about subatomic particles.

After 1964, Higgs published less than 10 papers.
When his department would ask him how many papers, he published in a given year, he would reply "None."

It happened so often that he stared feeling like an "embarrassment to the department."

The University of Edinburgh, however, never fired Higgs because in 1980 he had been nominated for the Nobel Prize.

Higgs retired in 1996 and stayed on as an emeritus professor at Edinburg.

In 2012, experiments conducted at the CERN laboratory confirmed Higgs work and the existence of Higgs Particle.

And in 2013, Higgs was awarded the Noble Prize in physics and the University of Edinburgh got rewarded for being patient.

[UEMS Section of Surgery @UEMSSurg]

📺 What are you watching this weekend? For us, it is going to be a classic throwback: our first webinar "Polytrauma management" by Roman Pfeifer!

➡ https://t.co/KL0PhKa9IE

#UEMS #Webinar #Education #OnlineEducation #CME #Surgery #PolyTrauma

[UEMS Section of Surgery @UEMSSurg]

🎙️Next #webinar Surgery Thursday 12 Oct. 18:30 CET Recurrent rectal cancer: diagnosis and principles of treatment by Ibrahim Edhemovic!

🌍Organised in collaboration with Berufsverband Österreichischer Chirurgen

➡️Register https://t.co/wD2p3dGXfU @ESSOnews #SurgicalOncology

[Johanna Louhimo @JLouhimo]

"Even the blind squirrel will find a nut sometime"
Wonderful workshop by @LaraVarpio in #MedEdontheEdge #KI

[Malin Sund @MalinASund]

Har du läst/hört om denna studie på @BBC och i andra medier? Viktig och chockerande studie publicerad i @BJSurgery idag! Se även redaktörernas ledare! 😖😷⬇️

https://t.co/uPgLmVfFVA

https://t.co/1MlJNsWo66

@SKFredaktion @lakartidn @lakarforbundet @sls_sv